IL10 and rheumatoid arthritis: Miyata et al. [52] believed that the significant decrease in the synthesis of mRNA of IL-4 and IL10 is related to the progress and activity of RA, so the possibility of using IL-4 and IL10 to treat progressive or intractable RA should be considered.